Research Grade Etaracizumab ( 埃达组单抗 )
- 发布日期： 2020-10-28
- 更新日期： 2025-10-24
产品详请
| 产地 |
中国
|
| 品牌 |
Chemstan
|
| 货号 |
CSD00151
|
| 保存条件 |
store at -80℃
|
| 用途 |
仅用于科研用途
|
| 应用范围 |
|
| 抗原来源 |
CHO cells
|
| CAS编号 |
892553-42-3
|
| 保质期 |
一年
|
| 抗体名 |
Etaracizumab ( 埃达组单抗 )
|
| 是否单克隆 |
|
| 克隆性 |
|
| 靶点 |
ITGAV_ITGB3[Homo sapiens]
|
| 适应物种 |
|
| 形态 |
|
| 宿主 |
|
| 标记物 |
|
| 包装规格 |
1mg/ml
|
| 纯度 |
%
|
| 亚型 |
|
| 标识物 |
|
| 浓度 |
95%
|
| 免疫原 |
|
| 是否进口 |
否
|
Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.
货号（Catalog No.）
CSD00151
通用名INN
Etaracizumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.
别名(Alternative names)
MEDI-522,hLM60
靶点;物种(Specificity target name;species)
ITGAV_ITGB3[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG1-nd
化学信息
CAS
892553-42-3
存储条件(Storage)
store at -80°C
Note
For research use only. Not suitable for clinical or therapeutic use.
